Evaluation of Kaletra Therapy Over the Long-term.

Trial Profile

Evaluation of Kaletra Therapy Over the Long-term.

Phase of Trial: Phase IV

Latest Information Update: 09 Aug 2011

At a glance

  • Drugs Lopinavir/ritonavir (Primary)
  • Indications HIV infections
  • Focus Therapeutic Use
  • Sponsors Abbott Laboratories
  • Most Recent Events

    • 10 Jun 2017 Biomarkers information updated
    • 30 Jun 2011 Actual end date (1 Jun 2010) added as reported by ClinicalTrials.gov.
    • 30 Jun 2011 Secondary endpoint identified as CD4+ cell count and viral- oad as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top